nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—SLC16A1—Methotrexate—lymphatic system cancer	0.262	1	CbGbCtD
Niacin—SLC16A3—Azacitidine—Fludarabine—lymphatic system cancer	0.0121	0.514	CbGdCrCtD
Niacin—SLC16A3—Azacitidine—Cytarabine—lymphatic system cancer	0.0115	0.486	CbGdCrCtD
Niacin—Skin ulcer—Methotrexate—lymphatic system cancer	0.00204	0.00285	CcSEcCtD
Niacin—Hypotension—Teniposide—lymphatic system cancer	0.00203	0.00284	CcSEcCtD
Niacin—Necrosis—Methotrexate—lymphatic system cancer	0.00202	0.00283	CcSEcCtD
Niacin—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00202	0.00282	CcSEcCtD
Niacin—Arthralgia—Fludarabine—lymphatic system cancer	0.00199	0.00279	CcSEcCtD
Niacin—Myalgia—Fludarabine—lymphatic system cancer	0.00199	0.00279	CcSEcCtD
Niacin—Haemoglobin—Bleomycin—lymphatic system cancer	0.00198	0.00277	CcSEcCtD
Niacin—Haemorrhage—Bleomycin—lymphatic system cancer	0.00197	0.00276	CcSEcCtD
Niacin—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00196	0.00275	CcSEcCtD
Niacin—Dyspnoea—Teniposide—lymphatic system cancer	0.00194	0.00271	CcSEcCtD
Niacin—Oedema—Fludarabine—lymphatic system cancer	0.00191	0.00267	CcSEcCtD
Niacin—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00191	0.00267	CcSEcCtD
Niacin—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00189	0.00265	CcSEcCtD
Niacin—Decreased appetite—Teniposide—lymphatic system cancer	0.00189	0.00264	CcSEcCtD
Niacin—Vomiting—Mechlorethamine—lymphatic system cancer	0.00187	0.00262	CcSEcCtD
Niacin—Stomatitis—Carmustine—lymphatic system cancer	0.00187	0.00262	CcSEcCtD
Niacin—Rash—Mechlorethamine—lymphatic system cancer	0.00186	0.0026	CcSEcCtD
Niacin—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00186	0.0026	CcSEcCtD
Niacin—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00185	0.00258	CcSEcCtD
Niacin—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00184	0.00258	CcSEcCtD
Niacin—Flushing—Bleomycin—lymphatic system cancer	0.00183	0.00256	CcSEcCtD
Niacin—Anorexia—Fludarabine—lymphatic system cancer	0.00182	0.00255	CcSEcCtD
Niacin—Stomatitis—Vincristine—lymphatic system cancer	0.00178	0.0025	CcSEcCtD
Niacin—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00178	0.00249	CcSEcCtD
Niacin—Chills—Bleomycin—lymphatic system cancer	0.00177	0.00248	CcSEcCtD
Niacin—Skin discolouration—Methotrexate—lymphatic system cancer	0.00176	0.00246	CcSEcCtD
Niacin—Bone disorder—Methotrexate—lymphatic system cancer	0.00176	0.00246	CcSEcCtD
Niacin—Sweating—Vincristine—lymphatic system cancer	0.00175	0.00246	CcSEcCtD
Niacin—Nausea—Mechlorethamine—lymphatic system cancer	0.00175	0.00245	CcSEcCtD
Niacin—Hyperbilirubinaemia—Methotrexate—lymphatic system cancer	0.00174	0.00244	CcSEcCtD
Niacin—Alopecia—Bleomycin—lymphatic system cancer	0.00174	0.00244	CcSEcCtD
Niacin—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00174	0.00244	CcSEcCtD
Niacin—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00174	0.00243	CcSEcCtD
Niacin—Jaundice—Mitoxantrone—lymphatic system cancer	0.00174	0.00243	CcSEcCtD
Niacin—Haemoglobin—Carmustine—lymphatic system cancer	0.00173	0.00242	CcSEcCtD
Niacin—Urticaria—Teniposide—lymphatic system cancer	0.00173	0.00242	CcSEcCtD
Niacin—Haemorrhage—Carmustine—lymphatic system cancer	0.00172	0.00241	CcSEcCtD
Niacin—Abdominal pain—Teniposide—lymphatic system cancer	0.00172	0.0024	CcSEcCtD
Niacin—Body temperature increased—Teniposide—lymphatic system cancer	0.00172	0.0024	CcSEcCtD
Niacin—Erythema—Bleomycin—lymphatic system cancer	0.00171	0.0024	CcSEcCtD
Niacin—Paraesthesia—Fludarabine—lymphatic system cancer	0.00171	0.0024	CcSEcCtD
Niacin—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00171	0.0024	CcSEcCtD
Niacin—Hyperuricaemia—Methotrexate—lymphatic system cancer	0.00171	0.00239	CcSEcCtD
Niacin—Sweating—Mitoxantrone—lymphatic system cancer	0.00171	0.00239	CcSEcCtD
Niacin—Dyspnoea—Fludarabine—lymphatic system cancer	0.0017	0.00238	CcSEcCtD
Niacin—Oedema peripheral—Carmustine—lymphatic system cancer	0.00169	0.00237	CcSEcCtD
Niacin—Dyspepsia—Fludarabine—lymphatic system cancer	0.00168	0.00235	CcSEcCtD
Niacin—Decreased appetite—Fludarabine—lymphatic system cancer	0.00166	0.00232	CcSEcCtD
Niacin—Visual impairment—Carmustine—lymphatic system cancer	0.00166	0.00232	CcSEcCtD
Niacin—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00165	0.00231	CcSEcCtD
Niacin—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00163	0.00229	CcSEcCtD
Niacin—Pain—Fludarabine—lymphatic system cancer	0.00163	0.00229	CcSEcCtD
Niacin—Blood uric acid increased—Methotrexate—lymphatic system cancer	0.00162	0.00226	CcSEcCtD
Niacin—Eye disorder—Carmustine—lymphatic system cancer	0.00161	0.00225	CcSEcCtD
Niacin—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00161	0.00225	CcSEcCtD
Niacin—Rhinitis—Mitoxantrone—lymphatic system cancer	0.0016	0.00224	CcSEcCtD
Niacin—Hypersensitivity—Teniposide—lymphatic system cancer	0.0016	0.00224	CcSEcCtD
Niacin—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.0016	0.00224	CcSEcCtD
Niacin—Hepatitis—Mitoxantrone—lymphatic system cancer	0.0016	0.00224	CcSEcCtD
Niacin—Flushing—Carmustine—lymphatic system cancer	0.0016	0.00224	CcSEcCtD
Niacin—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.00159	0.00222	CcSEcCtD
Niacin—Asthenia—Teniposide—lymphatic system cancer	0.00156	0.00218	CcSEcCtD
Niacin—Pruritus—Teniposide—lymphatic system cancer	0.00154	0.00215	CcSEcCtD
Niacin—Arrhythmia—Carmustine—lymphatic system cancer	0.00154	0.00215	CcSEcCtD
Niacin—Leukopenia—Bleomycin—lymphatic system cancer	0.00154	0.00215	CcSEcCtD
Niacin—Alopecia—Carmustine—lymphatic system cancer	0.00152	0.00213	CcSEcCtD
Niacin—Skin exfoliation—Methotrexate—lymphatic system cancer	0.00151	0.00212	CcSEcCtD
Niacin—Body temperature increased—Fludarabine—lymphatic system cancer	0.00151	0.00211	CcSEcCtD
Niacin—Vaginal infection—Methotrexate—lymphatic system cancer	0.0015	0.0021	CcSEcCtD
Niacin—Malnutrition—Carmustine—lymphatic system cancer	0.0015	0.0021	CcSEcCtD
Niacin—Erythema—Carmustine—lymphatic system cancer	0.0015	0.0021	CcSEcCtD
Niacin—Cough—Bleomycin—lymphatic system cancer	0.0015	0.0021	CcSEcCtD
Niacin—Angiopathy—Vincristine—lymphatic system cancer	0.00149	0.00209	CcSEcCtD
Niacin—Diarrhoea—Teniposide—lymphatic system cancer	0.00149	0.00208	CcSEcCtD
Niacin—Myalgia—Bleomycin—lymphatic system cancer	0.00146	0.00204	CcSEcCtD
Niacin—Alopecia—Vincristine—lymphatic system cancer	0.00145	0.00203	CcSEcCtD
Niacin—Chills—Mitoxantrone—lymphatic system cancer	0.00143	0.00201	CcSEcCtD
Niacin—Urine output increased—Methotrexate—lymphatic system cancer	0.00143	0.00201	CcSEcCtD
Niacin—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00143	0.002	CcSEcCtD
Niacin—Alopecia—Mitoxantrone—lymphatic system cancer	0.00141	0.00198	CcSEcCtD
Niacin—Vision blurred—Carmustine—lymphatic system cancer	0.00141	0.00198	CcSEcCtD
Niacin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00141	0.00197	CcSEcCtD
Niacin—Oedema—Bleomycin—lymphatic system cancer	0.0014	0.00196	CcSEcCtD
Niacin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.0014	0.00196	CcSEcCtD
Niacin—Erythema—Mitoxantrone—lymphatic system cancer	0.00139	0.00195	CcSEcCtD
Niacin—Vomiting—Teniposide—lymphatic system cancer	0.00138	0.00193	CcSEcCtD
Niacin—Asthenia—Fludarabine—lymphatic system cancer	0.00137	0.00192	CcSEcCtD
Niacin—Rash—Teniposide—lymphatic system cancer	0.00137	0.00192	CcSEcCtD
Niacin—Dermatitis—Teniposide—lymphatic system cancer	0.00137	0.00192	CcSEcCtD
Niacin—Headache—Teniposide—lymphatic system cancer	0.00136	0.00191	CcSEcCtD
Niacin—Pruritus—Fludarabine—lymphatic system cancer	0.00135	0.00189	CcSEcCtD
Niacin—Leukopenia—Carmustine—lymphatic system cancer	0.00134	0.00188	CcSEcCtD
Niacin—Anorexia—Bleomycin—lymphatic system cancer	0.00133	0.00187	CcSEcCtD
Niacin—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00132	0.00185	CcSEcCtD
Niacin—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00131	0.00184	CcSEcCtD
Niacin—Polyuria—Methotrexate—lymphatic system cancer	0.00131	0.00184	CcSEcCtD
Niacin—Hypotension—Bleomycin—lymphatic system cancer	0.00131	0.00183	CcSEcCtD
Niacin—Diarrhoea—Fludarabine—lymphatic system cancer	0.00131	0.00183	CcSEcCtD
Niacin—Nausea—Teniposide—lymphatic system cancer	0.00129	0.00181	CcSEcCtD
Niacin—Vertigo—Vincristine—lymphatic system cancer	0.00128	0.0018	CcSEcCtD
Niacin—Leukopenia—Vincristine—lymphatic system cancer	0.00128	0.00179	CcSEcCtD
Niacin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00128	0.00179	CcSEcCtD
Niacin—Myalgia—Carmustine—lymphatic system cancer	0.00127	0.00178	CcSEcCtD
Niacin—Paraesthesia—Bleomycin—lymphatic system cancer	0.00126	0.00176	CcSEcCtD
Niacin—Dyspnoea—Bleomycin—lymphatic system cancer	0.00125	0.00175	CcSEcCtD
Niacin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00125	0.00174	CcSEcCtD
Niacin—Oedema—Carmustine—lymphatic system cancer	0.00122	0.00171	CcSEcCtD
Niacin—Decreased appetite—Bleomycin—lymphatic system cancer	0.00122	0.0017	CcSEcCtD
Niacin—Myalgia—Vincristine—lymphatic system cancer	0.00122	0.0017	CcSEcCtD
Niacin—Cough—Mitoxantrone—lymphatic system cancer	0.00121	0.0017	CcSEcCtD
Niacin—Vomiting—Fludarabine—lymphatic system cancer	0.00121	0.0017	CcSEcCtD
Niacin—Rash—Fludarabine—lymphatic system cancer	0.0012	0.00169	CcSEcCtD
Niacin—Dermatitis—Fludarabine—lymphatic system cancer	0.0012	0.00168	CcSEcCtD
Niacin—Pain—Bleomycin—lymphatic system cancer	0.0012	0.00168	CcSEcCtD
Niacin—Headache—Fludarabine—lymphatic system cancer	0.0012	0.00167	CcSEcCtD
Niacin—Tachycardia—Carmustine—lymphatic system cancer	0.00119	0.00167	CcSEcCtD
Niacin—Myalgia—Mitoxantrone—lymphatic system cancer	0.00118	0.00166	CcSEcCtD
Niacin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00118	0.00166	CcSEcCtD
Niacin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00117	0.00163	CcSEcCtD
Niacin—Oedema—Vincristine—lymphatic system cancer	0.00117	0.00163	CcSEcCtD
Niacin—Anorexia—Carmustine—lymphatic system cancer	0.00116	0.00163	CcSEcCtD
Niacin—Hypotension—Carmustine—lymphatic system cancer	0.00114	0.0016	CcSEcCtD
Niacin—Oedema—Mitoxantrone—lymphatic system cancer	0.00114	0.00159	CcSEcCtD
Niacin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00114	0.00159	CcSEcCtD
Niacin—Nausea—Fludarabine—lymphatic system cancer	0.00113	0.00159	CcSEcCtD
Niacin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00113	0.00158	CcSEcCtD
Niacin—Shock—Mitoxantrone—lymphatic system cancer	0.00112	0.00157	CcSEcCtD
Niacin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00111	0.00156	CcSEcCtD
Niacin—Urticaria—Bleomycin—lymphatic system cancer	0.00111	0.00156	CcSEcCtD
Niacin—Anorexia—Vincristine—lymphatic system cancer	0.00111	0.00156	CcSEcCtD
Niacin—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00111	0.00155	CcSEcCtD
Niacin—Body temperature increased—Bleomycin—lymphatic system cancer	0.00111	0.00155	CcSEcCtD
Niacin—Insomnia—Carmustine—lymphatic system cancer	0.0011	0.00155	CcSEcCtD
Niacin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.0011	0.00155	CcSEcCtD
Niacin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.0011	0.00154	CcSEcCtD
Niacin—Paraesthesia—Carmustine—lymphatic system cancer	0.0011	0.00154	CcSEcCtD
Niacin—Hypotension—Vincristine—lymphatic system cancer	0.00109	0.00153	CcSEcCtD
Niacin—Dyspnoea—Carmustine—lymphatic system cancer	0.00109	0.00153	CcSEcCtD
Niacin—Somnolence—Carmustine—lymphatic system cancer	0.00109	0.00152	CcSEcCtD
Niacin—Anorexia—Mitoxantrone—lymphatic system cancer	0.00108	0.00152	CcSEcCtD
Niacin—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00106	0.00149	CcSEcCtD
Niacin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00106	0.00149	CcSEcCtD
Niacin—Decreased appetite—Carmustine—lymphatic system cancer	0.00106	0.00149	CcSEcCtD
Niacin—Hypotension—Mitoxantrone—lymphatic system cancer	0.00106	0.00149	CcSEcCtD
Niacin—Insomnia—Vincristine—lymphatic system cancer	0.00105	0.00148	CcSEcCtD
Niacin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00105	0.00148	CcSEcCtD
Niacin—Paraesthesia—Vincristine—lymphatic system cancer	0.00105	0.00147	CcSEcCtD
Niacin—Pain—Carmustine—lymphatic system cancer	0.00104	0.00146	CcSEcCtD
Niacin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00103	0.00145	CcSEcCtD
Niacin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00103	0.00144	CcSEcCtD
Niacin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00102	0.00143	CcSEcCtD
Niacin—Decreased appetite—Vincristine—lymphatic system cancer	0.00101	0.00142	CcSEcCtD
Niacin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00101	0.00142	CcSEcCtD
Niacin—Somnolence—Mitoxantrone—lymphatic system cancer	0.00101	0.00141	CcSEcCtD
Niacin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00101	0.00141	CcSEcCtD
Niacin—Asthenia—Bleomycin—lymphatic system cancer	0.001	0.00141	CcSEcCtD
Niacin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.001	0.0014	CcSEcCtD
Niacin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000999	0.0014	CcSEcCtD
Niacin—Pain—Vincristine—lymphatic system cancer	0.000997	0.0014	CcSEcCtD
Niacin—Pruritus—Bleomycin—lymphatic system cancer	0.00099	0.00139	CcSEcCtD
Niacin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000987	0.00138	CcSEcCtD
Niacin—Pain—Mitoxantrone—lymphatic system cancer	0.000971	0.00136	CcSEcCtD
Niacin—Abdominal pain—Carmustine—lymphatic system cancer	0.000966	0.00135	CcSEcCtD
Niacin—Body temperature increased—Carmustine—lymphatic system cancer	0.000966	0.00135	CcSEcCtD
Niacin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000954	0.00134	CcSEcCtD
Niacin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000929	0.0013	CcSEcCtD
Niacin—Abdominal pain—Vincristine—lymphatic system cancer	0.000922	0.00129	CcSEcCtD
Niacin—Body temperature increased—Vincristine—lymphatic system cancer	0.000922	0.00129	CcSEcCtD
Niacin—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000916	0.00128	CcSEcCtD
Niacin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000902	0.00126	CcSEcCtD
Niacin—Hypersensitivity—Carmustine—lymphatic system cancer	0.0009	0.00126	CcSEcCtD
Niacin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000898	0.00126	CcSEcCtD
Niacin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000898	0.00126	CcSEcCtD
Niacin—Vomiting—Bleomycin—lymphatic system cancer	0.00089	0.00125	CcSEcCtD
Niacin—Rash—Bleomycin—lymphatic system cancer	0.000882	0.00124	CcSEcCtD
Niacin—Dermatitis—Bleomycin—lymphatic system cancer	0.000882	0.00123	CcSEcCtD
Niacin—Asthenia—Carmustine—lymphatic system cancer	0.000877	0.00123	CcSEcCtD
Niacin—Stomatitis—Methotrexate—lymphatic system cancer	0.000865	0.00121	CcSEcCtD
Niacin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000859	0.0012	CcSEcCtD
Niacin—Sweating—Methotrexate—lymphatic system cancer	0.000851	0.00119	CcSEcCtD
Niacin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000837	0.00117	CcSEcCtD
Niacin—Asthenia—Vincristine—lymphatic system cancer	0.000837	0.00117	CcSEcCtD
Niacin—Diarrhoea—Carmustine—lymphatic system cancer	0.000836	0.00117	CcSEcCtD
Niacin—Nausea—Bleomycin—lymphatic system cancer	0.000831	0.00116	CcSEcCtD
Niacin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000815	0.00114	CcSEcCtD
Niacin—Dizziness—Carmustine—lymphatic system cancer	0.000808	0.00113	CcSEcCtD
Niacin—Haemoglobin—Methotrexate—lymphatic system cancer	0.000801	0.00112	CcSEcCtD
Niacin—Diarrhoea—Vincristine—lymphatic system cancer	0.000798	0.00112	CcSEcCtD
Niacin—Haemorrhage—Methotrexate—lymphatic system cancer	0.000796	0.00112	CcSEcCtD
Niacin—Hepatitis—Methotrexate—lymphatic system cancer	0.000796	0.00112	CcSEcCtD
Niacin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000777	0.00109	CcSEcCtD
Niacin—Vomiting—Carmustine—lymphatic system cancer	0.000777	0.00109	CcSEcCtD
Niacin—Dizziness—Vincristine—lymphatic system cancer	0.000771	0.00108	CcSEcCtD
Niacin—Rash—Carmustine—lymphatic system cancer	0.00077	0.00108	CcSEcCtD
Niacin—Dermatitis—Carmustine—lymphatic system cancer	0.00077	0.00108	CcSEcCtD
Niacin—Visual impairment—Methotrexate—lymphatic system cancer	0.000768	0.00108	CcSEcCtD
Niacin—Headache—Carmustine—lymphatic system cancer	0.000765	0.00107	CcSEcCtD
Niacin—Eye disorder—Methotrexate—lymphatic system cancer	0.000744	0.00104	CcSEcCtD
Niacin—Tinnitus—Methotrexate—lymphatic system cancer	0.000743	0.00104	CcSEcCtD
Niacin—Vomiting—Vincristine—lymphatic system cancer	0.000741	0.00104	CcSEcCtD
Niacin—Rash—Vincristine—lymphatic system cancer	0.000735	0.00103	CcSEcCtD
Niacin—Dermatitis—Vincristine—lymphatic system cancer	0.000735	0.00103	CcSEcCtD
Niacin—Headache—Vincristine—lymphatic system cancer	0.000731	0.00102	CcSEcCtD
Niacin—Nausea—Carmustine—lymphatic system cancer	0.000726	0.00102	CcSEcCtD
Niacin—Angiopathy—Methotrexate—lymphatic system cancer	0.000723	0.00101	CcSEcCtD
Niacin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000722	0.00101	CcSEcCtD
Niacin—Rash—Mitoxantrone—lymphatic system cancer	0.000716	0.001	CcSEcCtD
Niacin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000715	0.001	CcSEcCtD
Niacin—Chills—Methotrexate—lymphatic system cancer	0.000715	0.001	CcSEcCtD
Niacin—Headache—Mitoxantrone—lymphatic system cancer	0.000711	0.000997	CcSEcCtD
Niacin—Alopecia—Methotrexate—lymphatic system cancer	0.000704	0.000986	CcSEcCtD
Niacin—Erythema—Methotrexate—lymphatic system cancer	0.000693	0.000971	CcSEcCtD
Niacin—Malnutrition—Methotrexate—lymphatic system cancer	0.000693	0.000971	CcSEcCtD
Niacin—Nausea—Vincristine—lymphatic system cancer	0.000693	0.00097	CcSEcCtD
Niacin—Nausea—Mitoxantrone—lymphatic system cancer	0.000675	0.000945	CcSEcCtD
Niacin—Vision blurred—Methotrexate—lymphatic system cancer	0.000653	0.000915	CcSEcCtD
Niacin—Vertigo—Methotrexate—lymphatic system cancer	0.000623	0.000872	CcSEcCtD
Niacin—Leukopenia—Methotrexate—lymphatic system cancer	0.000621	0.000869	CcSEcCtD
Niacin—Cough—Methotrexate—lymphatic system cancer	0.000605	0.000847	CcSEcCtD
Niacin—Myalgia—Methotrexate—lymphatic system cancer	0.00059	0.000827	CcSEcCtD
Niacin—Arthralgia—Methotrexate—lymphatic system cancer	0.00059	0.000827	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000586	0.000821	CcSEcCtD
Niacin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000566	0.000793	CcSEcCtD
Niacin—Skin disorder—Methotrexate—lymphatic system cancer	0.00055	0.00077	CcSEcCtD
Niacin—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000547	0.000766	CcSEcCtD
Niacin—Anorexia—Methotrexate—lymphatic system cancer	0.000539	0.000755	CcSEcCtD
Niacin—Hypotension—Methotrexate—lymphatic system cancer	0.000529	0.000741	CcSEcCtD
Niacin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000516	0.000722	CcSEcCtD
Niacin—Insomnia—Methotrexate—lymphatic system cancer	0.000512	0.000717	CcSEcCtD
Niacin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000508	0.000712	CcSEcCtD
Niacin—Dyspnoea—Methotrexate—lymphatic system cancer	0.000504	0.000707	CcSEcCtD
Niacin—Somnolence—Methotrexate—lymphatic system cancer	0.000503	0.000705	CcSEcCtD
Niacin—Dyspepsia—Methotrexate—lymphatic system cancer	0.000498	0.000698	CcSEcCtD
Niacin—Decreased appetite—Methotrexate—lymphatic system cancer	0.000492	0.000689	CcSEcCtD
Niacin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000489	0.000684	CcSEcCtD
Niacin—Pain—Methotrexate—lymphatic system cancer	0.000484	0.000678	CcSEcCtD
Niacin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000463	0.000648	CcSEcCtD
Niacin—Urticaria—Methotrexate—lymphatic system cancer	0.00045	0.00063	CcSEcCtD
Niacin—Body temperature increased—Methotrexate—lymphatic system cancer	0.000447	0.000627	CcSEcCtD
Niacin—Abdominal pain—Methotrexate—lymphatic system cancer	0.000447	0.000627	CcSEcCtD
Niacin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000417	0.000584	CcSEcCtD
Niacin—Asthenia—Methotrexate—lymphatic system cancer	0.000406	0.000569	CcSEcCtD
Niacin—Pruritus—Methotrexate—lymphatic system cancer	0.0004	0.000561	CcSEcCtD
Niacin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000387	0.000542	CcSEcCtD
Niacin—Dizziness—Methotrexate—lymphatic system cancer	0.000374	0.000524	CcSEcCtD
Niacin—Vomiting—Methotrexate—lymphatic system cancer	0.00036	0.000504	CcSEcCtD
Niacin—Rash—Methotrexate—lymphatic system cancer	0.000357	0.0005	CcSEcCtD
Niacin—Dermatitis—Methotrexate—lymphatic system cancer	0.000356	0.000499	CcSEcCtD
Niacin—Headache—Methotrexate—lymphatic system cancer	0.000354	0.000497	CcSEcCtD
Niacin—Nausea—Methotrexate—lymphatic system cancer	0.000336	0.000471	CcSEcCtD
